DEF: Huron Consulting Reports Record 2025 Revenue, Strong Shareholder Returns
Proxy Statement
Huron Consulting Group Inc. announces record revenues and significant shareholder returns in 2025, driven by strategic execution and balanced capital allocation, as detailed in its latest proxy statement.
Summary
- Revenues before reimbursable expenses (RBR) grew 12% compared to 2024, reaching a record $1.66 billion in 2025, marking the fifth consecutive year of growth.
- Total stockholder return was 39% in 2025, with stock price appreciation of 68% from December 31, 2023, to December 31, 2025.
- Adjusted EBITDA margin expanded by 80 basis points to 14.3% in 2025, and adjusted diluted earnings per share (EPS) increased 21% to $7.83.
- Net income margin was 6.2% in 2025, down from 7.7% in 2024, primarily due to $7.7 million in non-cash impairment charges in 2025 and an $11.1 million litigation settlement gain in 2024.
- The company repurchased 1.2 million shares of common stock for $166 million and deployed $112 million on six strategic tuck-in acquisitions in 2025, maintaining a leverage ratio of 1.93.
- From fiscal year 2023 through 2025, RBR grew at a 10.5% compound annual growth rate, net income margin and adjusted EBITDA margin expanded by 170 and 200 basis points respectively, and diluted EPS and adjusted diluted EPS grew 83% and 59% respectively.
- The 2023-2025 performance share unit (PSU) cycle achieved a payout of 180% of target based on actual results for RBR and Adjusted Diluted EPS.
- The 2025 annual incentive program achieved a total payout of 102% of target, driven by strong performance in organic revenues, adjusted EBITDA margin, and strategic measures.
- The company's employee engagement score was 83 in 2025, surpassing the global benchmark of 75, and it was certified as a Great Place To Work for 15 consecutive years.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a strong performance year with record revenues, significant adjusted EBITDA and EPS growth, and robust shareholder returns, despite a slight dip in GAAP net income and EPS due to specific non-cash items. The strategic execution and positive outlook contribute to a favorable sentiment.
Positives
- Record Revenues before Reimbursable Expenses (RBR) of $1.66 billion in 2025, a 12% increase from 2024, marking the fifth consecutive year of growth.
- Strong Total Shareholder Return (TSR) of 39% in 2025 and 68% stock price appreciation from December 31, 2023, to December 31, 2025.
- Adjusted EBITDA Margin expanded by 80 basis points to 14.3% in 2025, demonstrating improved profitability.
- Adjusted Diluted EPS increased 21% to $7.83 in 2025, reflecting strong earnings growth on an adjusted basis.
- Successful capital allocation strategy, including $166 million in share repurchases (1.2 million shares) and $112 million for six strategic tuck-in acquisitions in 2025.
- Maintained a healthy leverage ratio of 1.93 as of December 31, 2025, indicating financial stability.
- Achieved 180% of target payout for the 2023-2025 performance share units (PSUs), reflecting strong long-term performance against financial goals.
- High employee engagement score of 83 in 2025, surpassing the global benchmark of 75, and numerous workplace accolades, highlighting a strong company culture and talent retention.
- 98% stockholder approval for the 2025 'say-on-pay' executive compensation, indicating strong investor confidence in compensation practices.
Negatives
- Net Income Margin decreased to 6.2% in 2025 from 7.7% in 2024, primarily due to $7.7 million in non-cash impairment charges in 2025 and an $11.1 million litigation settlement gain in 2024.
- GAAP Diluted EPS decreased to $5.84 in 2025 from $6.27 in 2024, influenced by the same factors affecting net income margin.
- Did not achieve the 2025 free cash flow goal, as stated in the strategic measures section, although specific target numbers were not provided in the summary.
Risks
- Potential for undue risk-taking in compensation plans, which is addressed by annual risk assessments.
- Risk of dilution for stockholders due to equity award grants, which the company aims to mitigate through its share repurchase program.
- Challenges in attracting, engaging, developing, rewarding, and retaining highly skilled professionals in a competitive talent market.
- Exposure to major technology, cybersecurity, and related operational risks, requiring continuous oversight.
- Financial risks, including foreign currency, credit risk, and interest rate exposure, managed through various strategies.
- Emerging climate risks that need to be identified and integrated into the enterprise risk management framework.
- Ethical considerations related to responsible AI, requiring robust governance and operational practices.
Future Outlook
The company outlined a refreshed strategy at its March 2025 investor day, focusing on five strategic priorities: sustaining accelerated growth in healthcare and education, growing the business in commercial industries, expanding global digital capability, executing on a solid foundation for margin expansion and organic reinvestment, and maintaining a strong balance sheet and cash flows while strategically deploying capital. Medium-term financial targets by 2029 include achieving low double-digit annual revenues before reimbursable expenses (RBR) growth, expanding adjusted EBITDA margin to 15-17%, converting 75% of annual adjusted EBITDA to free cash flow, and doubling adjusted diluted EPS.
Management Comments
- We are focused on the execution of the Company's strategy, delivering on our balanced capital allocation strategy, sustaining the alignment between Huron's management compensation programs and the interest of stockholders, and the advancement of our periodic board refreshment process.
- This refreshed focus, our disciplined execution, and the market tailwinds driving our business will continue to drive further value for our stockholders.
- Huron delivered another year of strong performance. Revenues before reimbursable expenses (RBR) grew 12% compared to 2024, resulting in record RBR and a fifth consecutive year of growth.
- We are pleased with our continued margin and earnings per share expansion and strong cash flows in 2025.
- Our professionals' expertise, skills and experience and our strong company culture are our biggest differentiators.
- We believe Huron's long-term success is enabled by a balanced compensation program that aligns stockholder value, enterprise objectives, and employee performance.
- The board and management are committed to thoughtfully managing our equity compensation programs while mitigating risk and dilution for stockholders.
- We are proud of the performance delivered by Huron's leadership team in 2025 and confident that our compensation philosophy and programs continue to effectively support the Company's strategy and long-term objectives.
Industry Context
StockSavvy.ai notes that Huron's strategic focus on accelerating growth in healthcare and education, expanding commercial industries, and enhancing global digital capabilities aligns well with broader industry trends emphasizing specialized expertise, digital transformation, and targeted M&A in the professional services sector. The company's strong employee engagement scores and consistent recognition as a 'Best Firm to Work For' suggest a significant competitive advantage in attracting and retaining top talent, which is crucial for success in the consulting industry.
Comparison to Industry Standards
- The company's employee engagement score of 83 in 2025 surpassed the Microsoft Viva Glint Employee Engagement global benchmark of 75.
- The coach quality score of 83 in 2025 was above the Glint Coach Quality global benchmark of 82.
- Huron's compensation peer group for 2025, used for executive compensation benchmarking, includes companies such as Blackbaud, Inc., FTI Consulting Inc., ICF International, Inc., Korn Ferry, and R1 RCM, Inc.
- As of July 2024, Huron's revenue positioning was at the 52nd percentile and market capitalization at the 20th percentile relative to its compensation peer group.
- The industry peer group for Total Shareholder Return (TSR) comparison (S-K Item 201(e)) includes CRA International, Inc. (CRAI), FTI Consulting, Inc. (FCN), ICF International, Inc. (ICFI), and Resources Connection, Inc. (RGP).
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Ekta Singh-Bushell | N/A | May 8, 2026 | Will not stand for re-election upon election of director nominees at the 2026 Annual Meeting. |
| Non-Executive Chairman of the Board | John McCartney | Hugh E. Sawyer | January 1, 2025 | Succession as part of the company's periodic board refreshment process. |
| Executive Vice President, General Counsel and Corporate Secretary | N/A (previously Corporate Vice President, Legal Affairs and Corporate Secretary) | Hope Katz | January 1, 2025 | Appointment to new role. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Declassification | Stockholders approved an amendment to declassify the board over a three-year period at the 2023 Annual Meeting. All directors will now stand for election at the 2026 Annual Meeting for one-year terms. | 2023 (approved), 2026 (fully effective) | Enhances accountability and responsiveness to stockholders by moving to annual director elections. |
| Board Size Reduction | The board size will decrease to eight directors immediately upon election of directors at the 2026 Annual Meeting. | May 8, 2026 | Aims to maintain a relatively small board composed principally of non-executive independent directors, potentially streamlining decision-making. |
| Board Leadership Structure | Formal separation of Chairman of the Board and Chief Executive Officer roles since 2010, with Hugh E. Sawyer as non-executive chairman, James H. Roth as executive vice chairman, client services, and C. Mark Hussey as CEO and President. | 2010 (separation), January 1, 2025 (Sawyer as Chairman) | Provides independent oversight and ensures the board acts in the long-term best interests of the company and stockholders. |
| Director Compensation Program Update | Increased annual cash retainer for non-employee directors from $75,000 to $80,000 and annual restricted stock unit grant from $170,000 to $180,000. Audit Committee chair retainer increased from $20,000 to $25,000. | May 12, 2025 | Aims to enhance the ability to attract and retain highly qualified directors and align their interests with long-term stockholder interests. |
| Clawback Policy Amendment | Amended and restated effective October 27, 2023, in accordance with Rule 10D-1 of the Securities Exchange Act of 1934 and Nasdaq listing standards. Further amended on February 14, 2025, to allow recovery of compensation for certain acts of misconduct. | October 27, 2023, and February 14, 2025 | Strengthens corporate governance by ensuring accountability for financial restatements and misconduct, aligning executive incentives with ethical conduct and financial integrity. |
| AI Strategy Oversight | The Technology and Information Security Committee reviews and oversees the company's AI strategy, governance, and operational practices, including risk management and ethical considerations. | N/A (ongoing oversight) | Addresses emerging technological risks and opportunities, ensuring responsible development and deployment of AI. |
Legal Proceedings
- In the second quarter of 2024, the company settled a litigation matter in which it was the plaintiff, resulting in a $15.0 million pre-tax gain.
Related Party Transactions
- Payments made to Stanford University (employer of Ms. Zumwalt), Brown University Health (employer of Mr. Markell), and Boston Medical Center Health System (employer of Ms. Brown) for consulting services comprised less than 0.18%, 0.06%, and 0.06% of Huron's annual revenues, respectively, during the prior three fiscal years. The board determined these relationships do not interfere with director independence.
- James H. Roth, Vice Chairman, Client Services, is an employee and director, receiving compensation for his executive role but not for director duties. His senior management agreement was extended until December 31, 2026.
Stakeholder Impact
- Shareholders benefited from a 39% Total Shareholder Return (TSR) in 2025 and 68% stock price appreciation from 2023-2025, along with $288 million in capital returned through share repurchases (2023-2025).
- Employees are positively impacted by the company's commitment to investing in their growth and development, fostering an inclusive culture, and providing competitive total rewards, evidenced by high employee engagement scores and workplace accolades.
- Clients are served through the company's focus on creating sound strategies, optimizing operations, accelerating digital transformation, and empowering organizations, aiming for greater client impact.
- Communities benefited from over 16,500 hours volunteered in 2025, with more than 4,200 employees participating in the annual Day of Service, supporting various causes globally.
- Management and executives are incentivized through compensation programs designed to align with stockholder value and enterprise objectives, with a significant portion of pay being at-risk and performance-based.
Next Steps
- Elect eight director nominees at the Annual Meeting on May 8, 2026.
- Conduct an advisory vote to approve the company's Executive Compensation at the Annual Meeting on May 8, 2026.
- Ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, at the Annual Meeting on May 8, 2026.
- Continue to execute the refreshed strategy to achieve further revenue growth and margin expansion, with medium-term financial targets by 2029.
- The Nominating and Corporate Governance Committee will continue to consider a variety of factors to enhance board composition, reduce average tenure, and ensure structured and orderly board succession.
- The board may periodically expand or contract as part of its periodic refreshment process.
- Maintain ongoing dialogue with stockholders regarding growth strategy, competitive positioning, financial performance, and executive compensation.
Key Dates
| Date | Description |
|---|---|
| 2002 | James H. Roth became a founding member of Huron. |
| 2004 | John McCartney joined the board. |
| December 2006 | H. Eugene Lockhart joined the board. |
| 2008 | J. Ronald Dail joined Huron through the acquisition of Stockamp & Associates. |
| November 2009 | James H. Roth joined the board. |
| 2010 | Huron formally separated the roles of chairman of the board and chief executive officer. |
| 2012 | Initial growth strategy outlined. |
| 2014 | Debra Zumwalt joined the board. |
| February 2018 | Hugh E. Sawyer joined the board. |
| 2021 | Divestiture of Life Sciences business. |
| 2022 | Joy T. Brown and Peter K. Markell joined the board. |
| January 1, 2023 | C. Mark Hussey appointed Chief Executive Officer and President; James H. Roth appointed Vice Chairman, Client Services. |
| 2023 | Stockholders approved an amendment to declassify the board over a three-year period. |
| October 27, 2023 | Company's incentive compensation recoupment policy amended and restated. |
| March 15, 2024 | Ernest W. Torain, Jr. departed. |
| Second quarter of 2024 | Settlement of a litigation matter where Huron was the plaintiff for $15.0 million pre-tax. |
| July 2024 | Compensation Committee approved the 2025 peer group. |
| Fourth quarter of 2024 | Divestiture of Studer Education practice. |
| December 31, 2024 | End of fiscal year 2024. |
| January 1, 2025 | Hugh E. Sawyer succeeded John McCartney as non-executive chairman of the board; Hope Katz appointed Executive Vice President and General Counsel; James H. Roth's senior management agreement became effective. |
| February 14, 2025 | Clawback policy further amended to provide the ability to recover compensation in connection with certain acts of misconduct. |
| March 2025 | Investor day where the refreshed strategy was outlined. |
| May 12, 2025 | Effective date for changes to the director compensation program. |
| December 31, 2025 | End of fiscal year 2025; end of the 2023-2025 PSU performance period. |
| January 1, 2026 | C. Mark Hussey's senior management agreement automatically extended. |
| February 2026 | Code of Business Conduct and Ethics updated. |
| March 1, 2026 | 2023 PSUs vested. |
| March 9, 2026 | Record Date for the Annual Meeting of Stockholders. |
| March 11, 2026 | Mr. Roth entered into an amendment to extend his agreement until December 31, 2026. |
| March 20, 2026 | Proxy Statement mailed to stockholders. |
| May 7, 2026 | Deadline to vote by phone or online for the Annual Meeting. |
| May 8, 2026 | Annual Meeting of Stockholders. |
| December 31, 2026 | End of fiscal year 2026; end of Mr. Roth's extended agreement term; end of 2024-2026 PSU performance period. |
| November 20, 2026 | Deadline for stockholder proposals for the next annual meeting to be included in the proxy statement. |
| January 8, 2027 | Earliest date for stockholder notice of business for the next annual meeting. |
| February 7, 2027 | Latest date for stockholder notice of business for the next annual meeting. |
| March 1, 2027 | 2024 PSUs will vest. |
| March 1, 2028 | 2025 PSUs will vest. |
| 2029 | Target year to expand adjusted EBITDA margin to 15-17% and double adjusted diluted EPS. |
Recommendation
buyThe company demonstrates strong underlying financial performance with record revenues, significant adjusted EBITDA and EPS growth, and robust shareholder returns. Strategic execution, balanced capital allocation including share repurchases and tuck-in acquisitions, and a clear future outlook with ambitious targets suggest continued positive momentum. While GAAP net income and EPS saw a slight dip due to specific non-cash items, the operational performance and adjusted metrics are very positive. The strong corporate governance and focus on human capital further support a positive long-term view, making it an attractive investment.
Keywords
Consulting, Professional Services, Huron Consulting Group, HURN, Financial Performance, Revenue Growth, EBITDA, EPS, Shareholder Return, Capital Allocation, Share Repurchase, Acquisitions, Executive Compensation, Corporate Governance, Board Refreshment, Risk Management, ESG, Sustainability, Healthcare Consulting, Education Consulting, Digital Transformation, Proxy Statement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.